Literature DB >> 27213693

C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus.

Supriya D Mahajan1, Vincent M Tutino2, Yonas Redae1, Hui Meng2, Adnan Siddiqui2, Trent M Woodruff3, James N Jarvis4, Teresa Hennon4, Stanley Schwartz1, Richard J Quigg1, Jessy J Alexander1.   

Abstract

Blood-brain barrier (BBB) dysfunction complicates central nervous system lupus, an important aspect of systemic lupus erythematosus. To gain insight into the underlying mechanism, vascular corrosion casts of brain were generated from the lupus mouse model, MRL/lpr mice and the MRL/MpJ congenic controls. Scanning electron microscopy of the casts showed loss of vascular endothelial cells in lupus mice compared with controls. Immunostaining revealed a significant increase in caspase 3 expression in the brain vascular endothelial cells, which suggests that apoptosis could be an important mechanism causing cell loss, and thereby loss of BBB integrity. Complement activation occurs in lupus resulting in increased generation of circulating C5a, which caused the endothelial layer to become 'leaky'. In this study, we show that C5a and lupus serum induced apoptosis in cultured human brain microvascular endothelial cells (HBMVECs), whereas selective C5a receptor 1 (C5aR1) antagonist reduced apoptosis in these cells, demonstrating C5a/C5aR1-dependence. Gene expression of initiator caspases, caspase 1 and caspase 8, and pro-apoptotic proteins death-associated protein kinase 1, Fas-associated protein (FADD), cell death-inducing DNA fragmentation factor 45 000 MW subunit A-like effector B (CIDEB) and BCL2-associated X protein were increased in HBMVECs treated with lupus serum or C5a, indicating that both the intrinsic and extrinsic apoptotic pathways could be critical mediators of brain endothelial cell apoptosis in this setting. Overall, our findings suggest that C5a/C5aR1 signalling induces apoptosis through activation of FADD, caspase 8/3 and CIDEB in brain endothelial cells in lupus. Further elucidation of the underlying apoptotic mechanisms mediating the reduced endothelial cell number is important in establishing the potential therapeutic effectiveness of C5aR1 inhibition that could prevent and/or reduce BBB alterations and preserve the physiological function of BBB in central nervous system lupus.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  apoptosis; blood-brain barrier; complement; endothelial cells; neurodegeneration

Mesh:

Substances:

Year:  2016        PMID: 27213693      PMCID: PMC4948033          DOI: 10.1111/imm.12619

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  74 in total

1.  Genes with homology to mammalian apoptosis regulators identified in zebrafish.

Authors:  N Inohara; G Nuñez
Journal:  Cell Death Differ       Date:  2000-05       Impact factor: 15.828

Review 2.  Complement receptors.

Authors:  M Krych; J P Atkinson; V M Holers
Journal:  Curr Opin Immunol       Date:  1992-02       Impact factor: 7.486

Review 3.  Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth.

Authors:  Liam G Coulthard; Trent M Woodruff
Journal:  J Immunol       Date:  2015-04-15       Impact factor: 5.422

Review 4.  The membrane attack complex of complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

5.  Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b.

Authors:  M K Pangburn; D C Morrison; R D Schreiber; H J Müller-Eberhard
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

6.  DFF45/ICAD restores cisplatin-induced nuclear fragmentation but not DNA cleavage in DFF45-deficient neuroblastoma cells.

Authors:  M Takahashi; T Ozaki; A Takahashi; M Miyauchi; S Ono; N Takada; T Koda; S Todo; T Kamijo; A Nakagawara
Journal:  Oncogene       Date:  2007-03-12       Impact factor: 9.867

7.  A critical role for Fas/CD-95 dependent signaling pathways in the pathogenesis of hyperoxia-induced brain injury.

Authors:  Mark Dzietko; Vinzenz Boos; Marco Sifringer; Oliver Polley; Bettina Gerstner; Kerstin Genz; Stefanie Endesfelder; Constanze Börner; Etienne Jacotot; David Chauvier; Michael Obladen; Christoph Bührer; Ursula Felderhoff-Mueser
Journal:  Ann Neurol       Date:  2008-12       Impact factor: 10.422

8.  Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.

Authors:  J P Buyon; J Tamerius; S Ordorica; B Young; S B Abramson
Journal:  Arthritis Rheum       Date:  1992-01

9.  Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse.

Authors:  Supriya D Mahajan; Ravikumar Aalinkeel; Donald E Sykes; Jessica L Reynolds; B Bindukumar; Adaffaras Adal; Mingshen Qi; Jennifer Toh; Gaixia Xu; Paras N Prasad; Stanley A Schwartz
Journal:  Brain Res       Date:  2008-02-13       Impact factor: 3.252

10.  Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.

Authors:  Ariel D Stock; Jing Wen; Jessica Doerner; Leal C Herlitz; Maria Gulinello; Chaim Putterman
Journal:  J Neuroinflammation       Date:  2015-11-06       Impact factor: 8.322

View more
  11 in total

1.  Identification of two phosphorylation sites essential for annexin A1 in blood-brain barrier protection after experimental intracerebral hemorrhage in rats.

Authors:  Zhong Wang; Zhouqing Chen; Junjie Yang; Ziying Yang; Jia Yin; Gang Zuo; Xiaochun Duan; Haitao Shen; Haiying Li; Gang Chen
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

2.  From functions to mechanisms of the prototypic complement C5 antibody BB5.1.

Authors:  Simon Milling
Journal:  Immunology       Date:  2020-10       Impact factor: 7.397

Review 3.  The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface.

Authors:  Ariel D Stock; Sivan Gelb; Ofer Pasternak; Ayal Ben-Zvi; Chaim Putterman
Journal:  Autoimmun Rev       Date:  2017-04-17       Impact factor: 9.754

Review 4.  Cognitive Dysfunction in Systemic Lupus Erythematosus: A Case for Initiating Trials.

Authors:  Nina Kello; Erik Anderson; Betty Diamond
Journal:  Arthritis Rheumatol       Date:  2019-08-07       Impact factor: 10.995

5.  Complement Receptor C5aR1 Plays an Evolutionarily Conserved Role in Successful Cardiac Regeneration.

Authors:  Niranjana Natarajan; Yamen Abbas; Donald M Bryant; Juan Manuel Gonzalez-Rosa; Michka Sharpe; Aysu Uygur; Lucas H Cocco-Delgado; Nhi Ngoc Ho; Norma P Gerard; Craig J Gerard; Calum A MacRae; Caroline E Burns; C Geoffrey Burns; Jessica L Whited; Richard T Lee
Journal:  Circulation       Date:  2018-01-18       Impact factor: 29.690

6.  Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway.

Authors:  Kavita Bisht; Giacomo Canesin; Tasneem Cheytan; Mailin Li; Zsuzsanna Nemeth; Eva Csizmadia; Trent M Woodruff; David E Stec; Andrew C Bulmer; Leo E Otterbein; Barbara Wegiel
Journal:  J Immunol       Date:  2019-04-05       Impact factor: 5.422

Review 7.  From Systemic Inflammation to Neuroinflammation: The Case of Neurolupus.

Authors:  Mykolas Bendorius; Chrystelle Po; Sylviane Muller; Hélène Jeltsch-David
Journal:  Int J Mol Sci       Date:  2018-11-13       Impact factor: 5.923

8.  High Concentration of C5a-Induced Mitochondria-Dependent Apoptosis in Murine Kidney Endothelial Cells.

Authors:  I-Jung Tsai; Wei-Chou Lin; Yao-Hsu Yang; Yu-Lin Tseng; Yen-Hung Lin; Chia-Hung Chou; Yong-Kwei Tsau
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

9.  The neuroprotective mechanism of 2-arachidonoylglycerol 2-AG against non-caspase-dependent apoptosis in mice hippocampal neurons following MCAO.

Authors:  He-Ying Zhong; Zhou Yang; Zhen Qiu; Shao-Qing Lei; Zhong-Yuan Xia
Journal:  Neuropsychiatr Dis Treat       Date:  2019-08-23       Impact factor: 2.570

10.  Selective cytotoxic and anti-metastatic activity in DU-145 prostate cancer cells induced by Annona muricata L. bark extract and phytochemical, annonacin.

Authors:  Kimberley Foster; Omolola Oyenihi; Sunelle Rademan; Joseph Erhabor; Motlalepula Matsabisa; James Barker; Moses K Langat; Amy Kendal-Smith; Helen Asemota; Rupika Delgoda
Journal:  BMC Complement Med Ther       Date:  2020-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.